gliclazide has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bours, V; Gielen, J; Lechanteur, C; Merville, MP; Mesnil, M; Princen, F; Rigo, JM; Robe, P | 1 |
1 other study(ies) available for gliclazide and Colonic Neoplasms
Article | Year |
---|---|
A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
Topics: 1-Octanol; Adenocarcinoma; Animals; Antiviral Agents; Cell Communication; Cell Survival; Colonic Neoplasms; Ganciclovir; Gap Junctions; Genetic Vectors; Glycyrrhetinic Acid; Herpesvirus 1, Human; Moloney murine leukemia virus; Rats; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 1999 |